| Initial public offering of up to [*] equity shares bearing face value of
Rs. 10 each ("Equity Shares") of Sresta Natural Bioproducts Limited ("Company") for cash at a price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) aggregating up to Rs. [*] crores comprising a fresh issue of up to [*] equity shares aggregating up to
Rs. 50.00 crores ("Fresh Issue") and an offer for sale of up to 7,030,962 equity shares aggregating up to Rs. [*] crores, comprising up to 2,250,000 equity shares aggregating up to Rs. [*] crores by Peepul Capital Fund III LLC ("PCF"), up to 1,524,251 equity shares aggregating up to Rs. [*] crores by Ventureast Life Fund III LLC ("VLF"), up to 2,184,010 equity shares aggregating up to Rs. [*] crores by Ventureast Trustee Company Private Limited (acting on behalf of the Biotechnology Venture Fund) ("Bio Fund") and up to 1,072,701 equity shares aggregating up to Rs. [*] crores by Ventureast Trustee Company Private Limited (acting on behalf of Ventureast Life Fund III) ("VLF III" and along with PCF, VLF and Bio Fund, collectively referred to as the "Selling Shareholders", and such equity shares cumulatively offered by the selling shareholders, the "Offered Shares") (such offer for sale by the selling shareholders, "Offer for Sale", and together with the fresh issue, the "Offer"). The offer shall constitute [*]% of the post-offer paid-up equity share capital of the company.
The price band and the minimum bid lot will be determined by the company.
The face value of the equity shares is Rs. 10 each and the offer price is [*] times the face value of the equity shares.
|